Simone A. Minnie, Olivia G. Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S. Nemychenkov, Kathleen S. Ensbey, Christine R. Schmidt, Samuel R. W. Legg, Melissa Comstock, Julie R. Boiko, Ethan Nelson, Shruti S. Bhise, Alec B. Wilkens, Motoko Koyama, Madhav V. Dhodapkar, Marta Chesi, Stanley R. Riddell, Damian J. Green, Andrew Spencer, Scott N. Furlan, Geoffrey R. Hill
{"title":"具有终末衰竭表型的 TIM-3+ CD8 T 细胞在血液恶性肿瘤中仍具有功能性","authors":"Simone A. Minnie, Olivia G. Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S. Nemychenkov, Kathleen S. Ensbey, Christine R. Schmidt, Samuel R. W. Legg, Melissa Comstock, Julie R. Boiko, Ethan Nelson, Shruti S. Bhise, Alec B. Wilkens, Motoko Koyama, Madhav V. Dhodapkar, Marta Chesi, Stanley R. Riddell, Damian J. Green, Andrew Spencer, Scott N. Furlan, Geoffrey R. Hill","doi":"10.1126/sciimmunol.adg1094","DOIUrl":null,"url":null,"abstract":"<div >Chronic antigen stimulation is thought to generate dysfunctional CD8 T cells. Here, we identify a CD8 T cell subset in the bone marrow tumor microenvironment that, despite an apparent terminally exhausted phenotype (T<sub>PHEX</sub>), expressed granzymes, perforin, and IFN-γ. Concurrent gene expression and DNA accessibility revealed that genes encoding these functional proteins correlated with <i>BATF</i> expression and motif accessibility. IFN-γ<sup>+</sup> T<sub>PHEX</sub> effectively killed myeloma with comparable efficacy to transitory effectors, and disease progression correlated with numerical deficits in IFN-γ<sup>+</sup> T<sub>PHEX</sub>. We also observed IFN-γ<sup>+</sup> T<sub>PHEX</sub> within CD19-targeted chimeric antigen receptor T cells, which killed CD19<sup>+</sup> leukemia cells. An IFN-γ<sup>+</sup> T<sub>PHEX</sub> gene signature was recapitulated in T<sub>EX</sub> cells from human cancers, including myeloma and lymphoma. Here, we characterize a T<sub>EX</sub> subset in hematological malignancies that paradoxically retains function and is distinct from dysfunctional T<sub>EX</sub> found in chronic viral infections. Thus, IFN-γ<sup>+</sup> T<sub>PHEX</sub> represent a potential target for immunotherapy of blood cancers.</div>","PeriodicalId":21734,"journal":{"name":"Science Immunology","volume":null,"pages":null},"PeriodicalIF":17.6000,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies\",\"authors\":\"Simone A. Minnie, Olivia G. Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S. Nemychenkov, Kathleen S. Ensbey, Christine R. Schmidt, Samuel R. W. Legg, Melissa Comstock, Julie R. Boiko, Ethan Nelson, Shruti S. Bhise, Alec B. Wilkens, Motoko Koyama, Madhav V. Dhodapkar, Marta Chesi, Stanley R. Riddell, Damian J. Green, Andrew Spencer, Scott N. Furlan, Geoffrey R. Hill\",\"doi\":\"10.1126/sciimmunol.adg1094\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div >Chronic antigen stimulation is thought to generate dysfunctional CD8 T cells. Here, we identify a CD8 T cell subset in the bone marrow tumor microenvironment that, despite an apparent terminally exhausted phenotype (T<sub>PHEX</sub>), expressed granzymes, perforin, and IFN-γ. Concurrent gene expression and DNA accessibility revealed that genes encoding these functional proteins correlated with <i>BATF</i> expression and motif accessibility. IFN-γ<sup>+</sup> T<sub>PHEX</sub> effectively killed myeloma with comparable efficacy to transitory effectors, and disease progression correlated with numerical deficits in IFN-γ<sup>+</sup> T<sub>PHEX</sub>. We also observed IFN-γ<sup>+</sup> T<sub>PHEX</sub> within CD19-targeted chimeric antigen receptor T cells, which killed CD19<sup>+</sup> leukemia cells. An IFN-γ<sup>+</sup> T<sub>PHEX</sub> gene signature was recapitulated in T<sub>EX</sub> cells from human cancers, including myeloma and lymphoma. Here, we characterize a T<sub>EX</sub> subset in hematological malignancies that paradoxically retains function and is distinct from dysfunctional T<sub>EX</sub> found in chronic viral infections. Thus, IFN-γ<sup>+</sup> T<sub>PHEX</sub> represent a potential target for immunotherapy of blood cancers.</div>\",\"PeriodicalId\":21734,\"journal\":{\"name\":\"Science Immunology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":17.6000,\"publicationDate\":\"2024-04-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Science Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.science.org/doi/10.1126/sciimmunol.adg1094\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.science.org/doi/10.1126/sciimmunol.adg1094","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
慢性抗原刺激被认为会产生功能失调的 CD8 T 细胞。在这里,我们发现了骨髓肿瘤微环境中的一个 CD8 T 细胞亚群,尽管其表型(TPHEX)明显终末衰竭,但它表达颗粒酶、穿孔素和 IFN-γ。同时进行的基因表达和 DNA 可及性研究发现,编码这些功能蛋白的基因与 BATF 的表达和图案可及性相关。IFN-γ+ TPHEX能有效杀死骨髓瘤,其疗效与过渡性效应物相当,而疾病进展与IFN-γ+ TPHEX的数量缺陷相关。我们还在 CD19 靶向嵌合抗原受体 T 细胞中观察到 IFN-γ+ TPHEX,它能杀死 CD19+ 白血病细胞。在人类癌症(包括骨髓瘤和淋巴瘤)的 TEX 细胞中也重现了 IFN-γ+ TPHEX 基因特征。在这里,我们描述了血液恶性肿瘤中 TEX 亚群的特征,这种亚群自相矛盾地保持着功能,并有别于慢性病毒感染中发现的功能失调 TEX。因此,IFN-γ+ TPHEX 是血液癌症免疫疗法的潜在靶点。
TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies
Chronic antigen stimulation is thought to generate dysfunctional CD8 T cells. Here, we identify a CD8 T cell subset in the bone marrow tumor microenvironment that, despite an apparent terminally exhausted phenotype (TPHEX), expressed granzymes, perforin, and IFN-γ. Concurrent gene expression and DNA accessibility revealed that genes encoding these functional proteins correlated with BATF expression and motif accessibility. IFN-γ+ TPHEX effectively killed myeloma with comparable efficacy to transitory effectors, and disease progression correlated with numerical deficits in IFN-γ+ TPHEX. We also observed IFN-γ+ TPHEX within CD19-targeted chimeric antigen receptor T cells, which killed CD19+ leukemia cells. An IFN-γ+ TPHEX gene signature was recapitulated in TEX cells from human cancers, including myeloma and lymphoma. Here, we characterize a TEX subset in hematological malignancies that paradoxically retains function and is distinct from dysfunctional TEX found in chronic viral infections. Thus, IFN-γ+ TPHEX represent a potential target for immunotherapy of blood cancers.
期刊介绍:
Science Immunology is a peer-reviewed journal that publishes original research articles in the field of immunology. The journal encourages the submission of research findings from all areas of immunology, including studies on innate and adaptive immunity, immune cell development and differentiation, immunogenomics, systems immunology, structural immunology, antigen presentation, immunometabolism, and mucosal immunology. Additionally, the journal covers research on immune contributions to health and disease, such as host defense, inflammation, cancer immunology, autoimmunity, allergy, transplantation, and immunodeficiency. Science Immunology maintains the same high-quality standard as other journals in the Science family and aims to facilitate understanding of the immune system by showcasing innovative advances in immunology research from all organisms and model systems, including humans.